tobramycin has been researched along with amoxicillin in 51 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (17.65) | 18.7374 |
| 1990's | 10 (19.61) | 18.2507 |
| 2000's | 22 (43.14) | 29.6817 |
| 2010's | 8 (15.69) | 24.3611 |
| 2020's | 2 (3.92) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Duewelhenke, N; Eysel, P; Krut, O | 1 |
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Espedido, BA; Iredell, JR; Partridge, SR | 1 |
| Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
| Bauernfeind, A; Keuleyan, E; Markovska, R; Queenan, AM; Rasshofer, R; Schneider, I | 1 |
| Cattoir, V; Nordmann, P; Poirel, L | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Andlovic, A; Jeverica, S; Karisik, E; Koren, S; Krizan-Hergouth, V; Livermore, DM; Mesko Meglic, K; Müller-Premru, M; Palepou, MF; Pike, R; Seme, K; Woodford, N | 1 |
| Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C | 1 |
| Bell, JM; Castanheira, M; Deshpande, LM; Jones, RN; Mendes, RE; Turnidge, JD | 1 |
| Campbell, L; Church, DL; Gregson, DB; Laupland, KB; Pitout, JD | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Carattoli, A; Ellington, MJ; Karisik, E; Livermore, DM; Underwood, A; Woodford, N | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Brozovic, A; Dowson, CG; Gazvoda, M; Košmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
| Weinstein, AJ | 1 |
| Arbeter, AM; Plotkin, SA | 1 |
| Kohl, S; Pickering, LK | 1 |
| Goncharova, EI | 1 |
| Basker, MJ; Slocombe, B; Sutherland, R | 1 |
| Gayer, J | 1 |
| Sanders, WE | 1 |
| Neu, HC | 1 |
| Boutin, F; Philip, V; Rovira, H; Saux, MC; Traissac, L | 1 |
| Bourget, P; Delouis, C; Demirdjian, S; Fernandez, H; Frydman, R | 1 |
| Kasuga, O; Matsushita, T; Yamaguchi, T | 1 |
| Davey, MR; van Iddekinge, B | 1 |
| Stassen, LP; van der Werken, C; van Vroonhoven, TJ | 1 |
| Gruninger, R; Guay, DR; Gustilo, RB; Peterson, PK; Tsukayama, DT; Wicklund, B | 1 |
| Dekkers, P; Gommers, D; Kluytmans, JA; Lachmann, B; Mouton, JW; van 't Veen, A | 1 |
| Erickson, BZ; Ross, RF; Tanner, AC | 1 |
| Li, RC; Nix, DE; Schentag, JJ | 1 |
| Schneeberger, P; Sluiter, E; Spanjaard, L; van Doorn, LJ | 1 |
| Albrecht, H; Bubert, A; Elsner, HA; Laufs, R; Mack, D; Sobottka, I | 1 |
| Martín, M; Mateu, E | 1 |
| van den Anker, JN | 1 |
| Anderson, R; Cockeran, R; de Gouveia, L; Feldman, C; Klugman, KP; Mitchell, TJ; Steel, HC; von Gottberg, A | 1 |
| Brohede, U; Engqvist, H; Forsgren, J; Mihranyan, A; Roos, S; Strømme, M | 1 |
| Belo, A; Bernardo, F; da Costa, PM; Gonçalves, J | 1 |
| Ciesiołka, J; Gaggelli, E; Gaggelli, N; Górska, A; Jeżowska-Bojczuk, M; Nagaj, J; Stokowa-Sołtys, K; Szczepanik, W; Valensin, G; Wrzesiński, J | 1 |
| Dai, C; Tang, S; Velkov, T; Xiao, X; Yang, X; Zhao, T | 1 |
| Abbasi, SA; Ali, S; Andleeb, S; Awan, UA; Imdad, K; Mughal, TA; Nasreen, S; Raja, SA | 1 |
| Caljon, B; Crombé, F; De Geyter, D; Demuyser, T; Janssen, T; Muyldermans, A; Piérard, D; Seyler, L; Vanstokstraeten, R; Wybo, I | 1 |
2 review(s) available for tobramycin and amoxicillin
| Article | Year |
|---|---|
Recent advances in antimicrobial therapy.
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Humans; Metronidazole; Sisomicin; Spectinomycin; Sulfamethoxazole; Ticarcillin; Tobramycin; Trimethoprim | 1977 |
[New developments in the treatment of typhoid (review of non-Soviet literature)].
Topics: Amoxicillin; Ampicillin; Anti-Infective Agents; Carrier State; Cefamandole; Cefazolin; Chloramphenicol; Doxycycline; Humans; Rifampin; Sulfamethoxazole; Tobramycin; Trimethoprim; Typhoid Fever | 1979 |
1 trial(s) available for tobramycin and amoxicillin
| Article | Year |
|---|---|
[Evaluation of the efficacy of the combination amoxicillin-clavulanic acid-tobramycin for the prevention of infections after surgery for ORL cancers].
Topics: Aged; Amoxicillin; Bacterial Infections; Clavulanic Acids; Clinical Protocols; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Otorhinolaryngologic Neoplasms; Postoperative Complications; Tobramycin | 1992 |
48 other study(ies) available for tobramycin and amoxicillin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
Topics: Australia; Bacterial Proteins; beta-Lactamases; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany.
Topics: Amino Acid Substitution; Bacterial Proteins; beta-Lactamases; Bulgaria; Catalysis; Germany; Hydrolysis; Isoenzymes; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Sequence Analysis, DNA | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Nationwide survey of CTX-M-type extended-spectrum beta-lactamases among Klebsiella pneumoniae isolates in Slovenian hospitals.
Topics: Anti-Bacterial Agents; beta-Lactamases; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Hospitals; Klebsiella pneumoniae; Microbial Sensitivity Tests; Slovenia | 2009 |
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence | 2009 |
Codetection of blaOXA-23-like gene (blaOXA-133) and blaOXA-58 in Acinetobacter radioresistens: report from the SENTRY antimicrobial surveillance program.
Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Molecular Sequence Data; Plasmids; Population Surveillance; Reverse Transcriptase Polymerase Chain Reaction; Transcription, Genetic | 2009 |
Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region.
Topics: beta-Lactamases; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Fluoroquinolones; Humans; Travel | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
Topics: beta-Lactamases; Computational Biology; Escherichia coli; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Plasmids; United Kingdom | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
Newer antibiotics: guidelines for use.
Topics: Amoxicillin; Anti-Bacterial Agents; Carbenicillin; Cephalosporins; Clindamycin; Doxycycline; Drug Combinations; Gentamicins; Humans; Minocycline; Rifampin; Spectinomycin; Sulfamethoxazole; Tobramycin; Trimethoprim | 1976 |
New antibiotics and old diseases.
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Drug Combinations; Humans; Penicillin Resistance; Spectinomycin; Sulfonamides; Tobramycin; Trimethoprim | 1977 |
Aminoglycoside-resistant enterococci.
Topics: Aminoglycosides; Amoxicillin; Drug Evaluation; Drug Synergism; Enterococcus faecalis; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Streptomycin; Tobramycin | 1977 |
[Therapy of pyelonephritis].
Topics: Amikacin; Amoxicillin; Ampicillin; Carbenicillin; Cephalosporins; Chloramphenicol; Gentamicins; Humans; Nalidixic Acid; Penicillin Resistance; Pivampicillin; Pyelonephritis; Sulfonamides; Tetracyclines; Tobramycin; Trimethoprim | 1977 |
New antibacterials: breakthrough or me-too?
Topics: Amoxicillin; Anti-Bacterial Agents; Cefazolin; Cephapirin; Drug Combinations; Drug Evaluation; Humans; Sulfadiazine; Sulfamethoxazole; Tobramycin; Trimethoprim | 1975 |
Newer antimicrobial agents.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Cephapirin; Cephradine; Clindamycin; Drug Combinations; Gastrointestinal Diseases; Humans; Minocycline; Penicillins; Respiratory Tract Infections; Sexually Transmitted Diseases; Sulfamethoxazole; Tobramycin; Trimethoprim; Urinary Tract Infections | 1975 |
[Determination of the ratio of serum concentrations of tobramycin between fetus and mother at birth. A model of small scale pharmacokinetics].
Topics: Amoxicillin; Birth Weight; Female; Gestational Age; Humans; Infant, Newborn; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Tobramycin | 1991 |
[The combined effects of aspoxicillin with aminoglycoside antibiotics on Pseudomonas aeruginosa].
Topics: Amikacin; Amoxicillin; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Pseudomonas aeruginosa; Tobramycin | 1990 |
Conservative approach to the management of pelvic inflammatory disease.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Humans; Metronidazole; Oxytetracycline; Pelvic Inflammatory Disease; Penicillin G; Prospective Studies; Tetracycline; Tobramycin | 1990 |
[Prevention of wound infection following abdominal surgery].
Topics: Abdomen; Amoxicillin; Drug Therapy, Combination; Humans; Metronidazole; Postoperative Care; Surgical Wound Infection; Tobramycin; Wound Healing | 1990 |
The effect of anaerobiosis on antistaphylococcal antibiotics.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anaerobiosis; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Clavulanic Acids; Clindamycin; Coagulase; Drug Therapy, Combination; Glycopeptides; Microbial Sensitivity Tests; Staphylococcus; Teicoplanin; Ticarcillin; Tobramycin; Vancomycin | 1988 |
Influence of pulmonary surfactant on in vitro bactericidal activities of amoxicillin, ceftazidime, and tobramycin.
Topics: Amoxicillin; Animals; Bacteria; Ceftazidime; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Pulmonary Surfactants; Rabbits; Tobramycin | 1995 |
Adaptation of the Sensititre broth microdilution technique to antimicrobial susceptibility testing of Mycoplasma hyopneumoniae.
Topics: Amoxicillin; Animals; Anti-Infective Agents, Urinary; Drug Resistance, Microbial; Erythromycin; Lincomycin; Microbial Sensitivity Tests; Mycoplasma; Nebramycin; Nitrofurans; Oxazolidinones; Oxytetracycline; Reproducibility of Results; Spectinomycin; Swine; Tylosin | 1993 |
The fractional maximal effect method: a new way to characterize the effect of antibiotic combinations and other nonlinear pharmacodynamic interactions.
Topics: Amoxicillin; Bacteria; Chloramphenicol; Drug Interactions; Drug Therapy, Combination; Microbial Sensitivity Tests; Ticarcillin; Tobramycin | 1993 |
Listeria meningitis during treatment of a meningococcal meningitis in an immunocompetent infant.
Topics: Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Cerebrospinal Fluid; Child, Preschool; Drug Therapy, Combination; Female; Humans; Immunocompetence; Listeria monocytogenes; Meningitis, Listeria; Meningitis, Meningococcal; Penicillin G; Penicillins; Tobramycin | 1996 |
Catalase-negative Listeria monocytogenes causing lethal sepsis and meningitis in an adult hematologic patient.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Antigens, Bacterial; Blotting, Western; Catalase; Ceftriaxone; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Diagnosis, Differential; Drug Therapy, Combination; Electrophoresis, Polyacrylamide Gel; Female; Humans; Listeria monocytogenes; Lymphoma, T-Cell, Cutaneous; Meningitis, Listeria; Penicillins; Polymerase Chain Reaction; Sepsis; Tobramycin | 1996 |
Antimicrobial resistance in enteric porcine Escherichia coli strains in Spain.
Topics: Amoxicillin; Animals; Animals, Newborn; Anti-Bacterial Agents; Cephalosporins; Colistin; Diarrhea; Drug Resistance, Microbial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests; Nebramycin; Neomycin; Quinolones; Spain; Swine; Swine Diseases | 2000 |
Molecular epidemiology of antibiotic-resistant Gram-negative bacilli in a neonatal intensive care unit during a nonoutbreak period.
Topics: Amoxicillin; Cefotaxime; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Length of Stay; Molecular Epidemiology; Penicillins; Risk Factors; Tobramycin | 2002 |
Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; Ceftriaxone; Doxycycline; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Macrolides; Microbial Sensitivity Tests; Streptococcus pneumoniae; Streptolysins; Tobramycin | 2007 |
Multifunctional implant coatings providing possibilities for fast antibiotics loading with subsequent slow release.
Topics: Agar; Amoxicillin; Anti-Bacterial Agents; Biomimetics; Cephalothin; Coated Materials, Biocompatible; Drug Delivery Systems; Durapatite; Gentamicins; Humans; Microbial Sensitivity Tests; Staphylococcus aureus; Time Factors; Titanium; Tobramycin | 2009 |
Field trial evaluating changes in prevalence and patterns of antimicrobial resistance among Escherichia coli and Enterococcus spp. isolated from growing broilers medicated with enrofloxacin, apramycin and amoxicillin.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Chickens; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Enterococcus; Escherichia coli; Feces; Fluoroquinolones; Microbial Sensitivity Tests; Nebramycin; Poultry Diseases | 2009 |
High affinity of copper(II) towards amoxicillin, apramycin and ristomycin. Effect of these complexes on the catalytic activity of HDV ribozyme.
Topics: Amoxicillin; Catalysis; Copper; Electron Spin Resonance Spectroscopy; Hepatitis Delta Virus; Magnetic Resonance Spectroscopy; Nebramycin; Ristocetin; RNA, Catalytic; RNA, Viral | 2013 |
Pharmacokinetics and relative bioavailability of an oral amoxicillin-apramycin combination in pigs.
Topics: Administration, Oral; Amoxicillin; Animals; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Cross-Over Studies; Nebramycin; Swine | 2017 |
Screening of Antibacterial Efficacy of Chitosan Encapsulated Probiotics (Lactococcus lactis and Lactobacillus curvattus) against Clinical Bacterial Pathogens.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Buffaloes; Ceftriaxone; Cephalothin; Cephradine; Chitosan; Chloramphenicol; Ciprofloxacin; Erythromycin; Lactobacillus; Lactococcus lactis; Probiotics; Tetracyclines; Tobramycin | 2022 |
Genotypic resistance determined by whole genome sequencing versus phenotypic resistance in 234 Escherichia coli isolates.
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Genotype; Gentamicins; Humans; Meropenem; Microbial Sensitivity Tests; Phenotype; Piperacillin; Retrospective Studies; Tazobactam; Tobramycin; Whole Genome Sequencing | 2023 |